ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 98 filers reported holding ENDOCYTE INC in Q2 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,589,000 | +25.9% | 174,800 | -40.7% | 0.02% | +21.4% |
| Q4 2017 | $1,262,000 | +167.4% | 294,800 | -11.9% | 0.01% | +180.0% |
| Q3 2017 | $472,000 | -6.0% | 334,800 | 0.0% | 0.01% | -16.7% |
| Q2 2017 | $502,000 | -0.2% | 334,800 | +71.0% | 0.01% | 0.0% |
| Q1 2017 | $503,000 | +0.8% | 195,800 | 0.0% | 0.01% | -14.3% |
| Q4 2016 | $499,000 | -17.5% | 195,800 | 0.0% | 0.01% | -22.2% |
| Q3 2016 | $605,000 | -3.8% | 195,800 | 0.0% | 0.01% | -10.0% |
| Q2 2016 | $629,000 | +16.1% | 195,800 | +11.9% | 0.01% | +11.1% |
| Q1 2016 | $542,000 | -22.7% | 174,900 | 0.0% | 0.01% | -30.8% |
| Q4 2015 | $701,000 | -12.5% | 174,900 | 0.0% | 0.01% | -23.5% |
| Q3 2015 | $801,000 | -11.8% | 174,900 | 0.0% | 0.02% | -5.6% |
| Q2 2015 | $908,000 | +16.1% | 174,900 | +40.0% | 0.02% | +12.5% |
| Q1 2015 | $782,000 | -0.5% | 124,900 | 0.0% | 0.02% | -11.1% |
| Q4 2014 | $786,000 | – | 124,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corbenic Partners LLC | 30,639 | $95,000 | 0.10% |
| Leisure Capital Management | 29,655 | $92,000 | 0.09% |
| Cribstone Capital Management, LLC | 32,541 | $101,000 | 0.08% |
| HIGHLAND CAPITAL MANAGEMENT LP | 442,656 | $1,372,000 | 0.06% |
| PINNACLE ASSOCIATES LTD | 898,096 | $2,784,000 | 0.06% |
| Bellevue Group AG | 100,000 | $310,000 | 0.06% |
| Baker Brothers Advisors | 1,695,865 | $5,257,000 | 0.06% |
| Curi RMB Capital, LLC | 217,885 | $675,000 | 0.04% |
| Spark Investment Management LLC | 116,300 | $360,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 244,192 | $757,000 | 0.02% |